ARCHIVES

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Early Treatment with CMX001 Can Help Prevent CMV Infection

September 27, 2013

Clinical Trial System Inefficient, UPCI Director Tells Senate

June 7, 2002

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

In Brief: NCI Ponders How Extra $40 Million Will Be Spent, Will Submit Plans to NCAB At Upcoming Meeting

January 14, 1983